全球狂犬病獸用疫苗市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計獸用狂犬病疫苗市場將從 2025 年的 8.5 億美元成長到 2034 年的 14.8 億美元，2026 年至 2034 年的複合年成長率為 6.37%。

隨著人們對動物健康和通用感染疾病的認知不斷提高，全球獸用狂犬病疫苗市場持續擴大。狂犬病仍然是一種嚴重的病毒性疾病，主要影響寵物和牲畜，尤其是在發展中地區。各國政府和動物福利組織正在積極推廣疫苗接種計劃，以控制和根除狂犬病在人類與動物之間的傳播。

推動成長要素包括伴侶動物強制疫苗接種法規和全球寵物擁有率的不斷提高。牲畜數量的增加和獸醫基礎設施的改善也促進了市場成長。疫苗配方技術和低溫運輸配送系統的進步提高了疫苗的可及性和有效性。

全球根除犬類傳播狂犬病的努力前景光明。公私合營和國際衛生計畫有望提高農村地區和醫療資源匱乏地區的疫苗接種率。持續的研發工作可望開發出更持久、更經濟的疫苗，進而提高整體疫苗覆蓋率。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球獸用狂犬疫苗市場：依應用領域分類

• 市場分析、洞察與預測
• 伴侶動物
• 家畜
• 野生動物

第5章：全球獸用狂犬疫苗市場：依通路分類

• 市場分析、洞察與預測
• 零售
• 電子商務
• 醫院和診所附設藥房

第6章：全球獸用狂犬疫苗市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Boehringer Ingelheim International GmbH
  • Zoetis Services LLC
  • Merck & Co. Inc
  • Elanco
  • BroadChem Philippines Biopharma Corporation
  • Virbac
  • Ceva
  • BiogAfA（C）NesisBagAfA3
  • Indian Immunologicals Ltd

The Rabies Veterinary Vaccines Market size is expected to reach USD 1.48 Billion in 2034 from USD 0.85 Billion (2025) growing at a CAGR of 6.37% during 2026-2034.

The Global Rabies Veterinary Vaccines Market is expanding as awareness about animal health and zoonotic diseases continues to increase. Rabies remains a serious viral disease affecting pets and livestock, especially in developing regions. Governments and animal welfare organizations are promoting vaccination programs to control and eliminate rabies transmission among animals and humans.

Major drivers include mandatory vaccination regulations for companion animals and rising pet ownership worldwide. Increasing livestock populations and initiatives to improve veterinary healthcare infrastructure are also supporting market growth. Advances in vaccine formulations and cold chain distribution systems have improved accessibility and effectiveness.

Future prospects appear promising as global campaigns aim to eliminate dog-mediated rabies. Public-private partnerships and international health programs are expected to strengthen vaccination coverage in rural and underserved areas. Continuous research and development efforts may result in longer-lasting and more cost-effective vaccines, boosting overall adoption rates.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Companion Animals
• Livestock Animals
• Wildlife Animals

By Distribution Channel

• Retail
• E-Commerce
• Hospital/Clinic Pharmacies

COMPANIES PROFILED

• Boehringer Ingelheim International GmbH, Zoetis Services LLC, Merck Co Inc, Elanco, BroadChem Philippines Biopharma Corporation, Virbac, Ceva, BiognesisBag, Indian Immunologicals Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RABIES VETERINARY VACCINES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Livestock Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Wildlife Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RABIES VETERINARY VACCINES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Retail Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. E-Commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hospital/Clinic Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RABIES VETERINARY VACCINES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Application
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Application
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Application
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Application
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Application
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL RABIES VETERINARY VACCINES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Boehringer Ingelheim International GmbH
  • 8.2.2 Zoetis Services LLC
  • 8.2.3 Merck & Co. Inc
  • 8.2.4 Elanco
  • 8.2.5 BroadChem Philippines Biopharma Corporation
  • 8.2.6 Virbac
  • 8.2.7 Ceva
  • 8.2.8 BiogAfA(C)NesisBagAfA3
  • 8.2.9 Indian Immunologicals Ltd